O
Optellum
Biotech & Life Sciences · Oxford, United Kingdom · Founded 2016
Developing an artificial intelligence software platform to support clinicians in lung cancer nodule management MoreLess
Optellum is a pioneering health technology startup focused on revolutionizing the early diagnosis and treatment of lung cancer. The company leverages advanced Artificial Intelligence (AI) and Machine Learning (ML) to develop decision support software that aids clinicians in identifying and managing lung cancer at its earliest stages. This innovative approach aims to improve patient outcomes by enabling earlier and more accurate diagnoses, which can significantly reduce waiting times for patients.
Optellum primarily serves healthcare providers, including top hospitals and physicians across Europe and the United States. The company collaborates closely with leading medical experts and institutions, including the Lung Cancer Initiative at Johnson & Johnson, to ensure its solutions are at the forefront of medical innovation.
Operating in the healthcare technology market, Optellum's business model revolves around the development and commercialization of its AI-based software. The company generates revenue by licensing its software to hospitals and medical practices, providing them with a powerful tool to enhance their diagnostic capabilities. This model not only supports the company's growth but also drives significant improvements in patient care.
Optellum's AI software has been validated through multi-center studies in Europe, demonstrating its ability to differentiate between benign and malignant lung nodules. This validation underscores the software's potential to transform lung cancer diagnosis and treatment, making it a valuable asset for healthcare providers aiming to improve patient outcomes.
In summary, Optellum is a cutting-edge health tech company that combines AI and ML to create diagnostic tools for early lung cancer detection. By partnering with top medical institutions and experts, the company aims to enhance the accuracy and efficiency of lung cancer diagnosis, ultimately improving patient care and reducing healthcare costs.
Keywords: AI, lung cancer, early diagnosis, healthcare, machine learning, medical software, patient care, hospitals, clinical experts, innovation.
Company overview
Optellum company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Oxford, United Kingdom
- Employees
- 51
- Open positions
- 1
- Dealroom signal
- 76.4
Valuation & funding
Optellum funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Nov 2025 | $5.7M | $23M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Jul 2025 | $1.8M | $37M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Mar 2025 | $7.4M | $70M | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Sep 2022 | $14M | $56M | Intuitive Ventures · The Oxford Trust · Mercia Asset Management · IQ Capital | ↗ |
| SUPPORT PROGRAM✓Other financing | Sep 2020 | $0 | — | Tech Nation | — |
| EARLY VC✓Equity / VC | Jul 2019 | Luminous Ventures | ↗ | ||
| GRANT✓Other financing | Dec 2017 | EIT Health | — | ||
| GRANT✓Other financing | Oct 2016 | EIT Health | — | ||
| SUPPORT PROGRAM✓Other financing | Jul 2016 | EIT Health | — | ||
| SUPPORT PROGRAM✓Other financing | Jan 2016 | EIT Health | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $4.5M | 0% | 51 |
| 2025 | $4.5M | 0% | 51 |
| 2024 | $4.5M | 0% | 48 |
| 2023 | $4.5M | +15.4% | 44 |
| 2022 | $3.9M | +30% | 45 |
| 2021 | $3M | +25% | 30 |
| 2020 | $2.4M | — | 24 |
Growth signals
Optellum website traffic
Latest recorded traffic for Optellum is 8.6K monthly website visits, down 3.4% over the last three months. Optellum's team grew 0% over the past year.
Hiring
Open positions at Optellum
Current openings linked to this company in Dealroom.
Comparisons
Optellum compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Optellum's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Optellum has talent and traffic
team presence
In the news
Latest news about Optellum
Recent press, funding announcements, and product moves mentioning Optellum — open to read from the original sources.
Market sentiment
What the market is saying about Optellum
An AI-synthesized read of the highest-engagement posts about Optellum on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Optellum’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





















